164 related articles for article (PubMed ID: 33161592)
1. Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia.
Bras AE; Osmani Z; de Haas V; Jongen-Lavrencic M; Te Marvelde JG; Zwaan CM; Mejstrikova E; Fernandez P; Szczepanski T; Orfao A; van Dongen JJM; van der Velden VHJ
Br J Haematol; 2021 Jun; 193(5):922-927. PubMed ID: 33161592
[TBL] [Abstract][Full Text] [Related]
2. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignment.
Drach D; Drach J; Glassl H; Gattringer C; Huber H
Leuk Res; 1993 May; 17(5):455-61. PubMed ID: 8388970
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
7. Immunological detection of myeloperoxidase in poorly differentiated acute leukemia.
Lepelley P; Preudhomme C; Sartiaux C; Ghevaert C; Lai JL; Iaru T; Fenaux P; Cosson A
Eur J Haematol; 1993 Mar; 50(3):155-9. PubMed ID: 8386105
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of unexpected acute myeloid leukemia and chronic lymphocytic leukemia: a case report demonstrating the perils of restricted panels in flow cytometric immunophenotyping.
Xie XY; Filie AC; Jasper GA; Fukushima PI; Stetler-Stevenson M
Cytometry; 2000 Apr; 42(2):114-7. PubMed ID: 10797449
[TBL] [Abstract][Full Text] [Related]
9. Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland.
Glier H; Heijnen I; Hauwel M; Dirks J; Quarroz S; Lehmann T; Rovo A; Arn K; Matthes T; Hogan C; Keller P; Dudkiewicz E; Stüssi G; Fernandez P;
J Immunol Methods; 2019 Dec; 475():112348. PubMed ID: 28760670
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric false myeloperoxidase-positive childhood B-lineage acute lymphoblastic leukemia.
Savaşan S; Buck S; Gadgeel M; Gabali A
Cytometry B Clin Cytom; 2018 May; 94(3):477-483. PubMed ID: 29244249
[TBL] [Abstract][Full Text] [Related]
11. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
12. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry.
Farahat N; van der Plas D; Praxedes M; Morilla R; Matutes E; Catovsky D
J Clin Pathol; 1994 Sep; 47(9):843-9. PubMed ID: 7962655
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry].
Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ
Zhonghua Er Ke Za Zhi; 2003 May; 41(5):334-7. PubMed ID: 14751050
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
Bendix-Hansen K; Kaspersen Nielsen H
Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
[TBL] [Abstract][Full Text] [Related]
16. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
Lanza F
Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
[No Abstract] [Full Text] [Related]
17. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
18. Detection of myeloperoxidase by flow cytometry in acute leukemia.
Nakase K; Sartor M; Bradstock
Cytometry; 1998 Aug; 34(4):198-202. PubMed ID: 9725460
[TBL] [Abstract][Full Text] [Related]
19. Applicability of a single 5 color cytoplasmic markers tube as primary panel for immunophenotyping of acute leukemia: A Gujarat Cancer and Research Institute experience.
Parikh BP; Patel SP; Raiya BN; Vora HH; Jetly DH
Indian J Cancer; 2016; 53(3):349-352. PubMed ID: 28244454
[TBL] [Abstract][Full Text] [Related]
20. Can threshold for MPO by flow cytometry be reduced in classifying acute leukaemia? A comparison of flow cytometric and cytochemical myeloperoxidase using different flow cytometric cut-offs.
Manivannan P; Puri V; Somasundaram V; Purohit A; Sharma RK; Dabas M; Saxena R
Hematology; 2015 Sep; 20(8):455-461. PubMed ID: 25537822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
